Literature DB >> 9690136

Extracellular matrix in renal cell carcinomas.

J Lohi1, I Leivo, J Oivula, V P Lehto, I Virtanen.   

Abstract

Extracellular matrix (ECM) may be divided into interstitial matrix and the basement membrane (BM). ECM influences a variety of epithelial cell behaviours, including proliferation, differentiation, and morphogenesis, maybe most widely studied in kidney morphogenesis. In carcinomas, including renal cell carcinomas (RCCs), these properties and interactions of cells with interstitial matrix and BM are disturbed. As a carcinoma with a tendency to spread to distant sites, RCC is an interesting target for the study of epithelial-stromal interactions. Among interstitial collagens, type VI collagen appears to be widely distributed in RCCs. Also EDA-fibronectin (EDA-Fn) as well as tenascin-C (Tn) are important stromal components especially in poorly differentiated carcinomas. BMs of RCC islets and those of tumor blood vessel endothelia may merge in poorly differentiated carcinomas. As a dynamic component of BMs, laminins (Ln) are important in kidney development and RCC progression. Type IV collagen and nidogen, other components of BMs in RCCs, are produced by stromal as well as epithelial cells. ECM proteins may function in RCC progression by binding and regulating the activity of growth factors e.g. transforming growth factor beta 1 and basic fibroblast growth factor. Also the expression of cell surface receptors for ECM is disturbed in RCCs. At least alpha v integrin (Int) and CD44 emerge in renal epithelial cells during malignant transformation. Papillary renal neoplasms differ from RCCs by cell adhesion receptor expression and BM composition as well as by ECM avascularity and capacity to bind growth factors, thus suggesting a distinct property for this renal tumor.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9690136     DOI: 10.14670/HH-13.785

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  10 in total

1.  Clinical significance of serum COL6A3 in pancreatic ductal adenocarcinoma.

Authors:  Christopher Y Kang; Jonathan Wang; Dierdre Axell-House; Pranay Soni; Mon-Li Chu; Galina Chipitsyna; Konrad Sarosiek; Jocelyn Sendecki; Terry Hyslop; Mazhar Al-Zoubi; Charles J Yeo; Hwyda A Arafat
Journal:  J Gastrointest Surg       Date:  2013-09-04       Impact factor: 3.452

2.  Tumor-specific expression and alternative splicing of the COL6A3 gene in pancreatic cancer.

Authors:  Hwyda Arafat; Melissa Lazar; Khalifa Salem; Galina Chipitsyna; Qiaoke Gong; Te-Cheng Pan; Rui-Zhu Zhang; Charles J Yeo; Mon-Li Chu
Journal:  Surgery       Date:  2011-06-30       Impact factor: 3.982

3.  Matrix-regulated integrin αvβ5 maintains α5β1-dependent desmoplastic traits prognostic of neoplastic recurrence.

Authors:  Janusz Franco-Barraza; Ralph Francescone; Tiffany Luong; Neelima Shah; Raj Madhani; Gil Cukierman; Essel Dulaimi; Karthik Devarajan; Brian L Egleston; Emmanuelle Nicolas; R Katherine Alpaugh; Ruchi Malik; Robert G Uzzo; John P Hoffman; Erica A Golemis; Edna Cukierman
Journal:  Elife       Date:  2017-01-31       Impact factor: 8.140

4.  Identification and classification of differentially expressed genes in renal cell carcinoma by expression profiling on a global human 31,500-element cDNA array.

Authors:  J M Boer; W K Huber; H Sültmann; F Wilmer; A von Heydebreck; S Haas; B Korn; B Gunawan; A Vente; L Füzesi; M Vingron; A Poustka
Journal:  Genome Res       Date:  2001-11       Impact factor: 9.043

Review 5.  The mesenchymal tumor microenvironment: a drug-resistant niche.

Authors:  Edna Cukierman; Daniel E Bassi
Journal:  Cell Adh Migr       Date:  2012-05-01       Impact factor: 3.405

6.  Elevated expression of stromal palladin predicts poor clinical outcome in renal cell carcinoma.

Authors:  Vivekanand Gupta; Daniel E Bassi; Jeffrey D Simons; Karthik Devarajan; Tahseen Al-Saleem; Robert G Uzzo; Edna Cukierman
Journal:  PLoS One       Date:  2011-06-28       Impact factor: 3.240

Review 7.  MMPs, tyrosine kinase signaling and extracellular matrix proteolysis in kidney cancer.

Authors:  Fiza Hashmi; Mehdi Mollapour; Gennady Bratslavsky; Dimitra Bourboulia
Journal:  Urol Oncol       Date:  2020-05-31       Impact factor: 2.954

8.  Collagen Type VI Alpha 3 Chain Promotes Epithelial-Mesenchymal Transition in Bladder Cancer Cells via Transforming Growth Factor β (TGF-β)/Smad Pathway.

Authors:  Yan Huang; Gang Li; Kai Wang; Zhongyi Mu; Qingpeng Xie; Hongchen Qu; Hang Lv; Bin Hu
Journal:  Med Sci Monit       Date:  2018-08-01

9.  Klotho inhibits EGF-induced cell migration in Caki-1 cells through inactivation of EGFR and p38 MAPK signaling pathways.

Authors:  Mehdi Dehghani; Reynolds K Brobey; Yue Wang; Glauco Souza; Robert J Amato; Kevin P Rosenblatt
Journal:  Oncotarget       Date:  2018-06-01

10.  Impact of Extracellular Matrix Components to Renal Cell Carcinoma Behavior.

Authors:  Sandra Majo; Sarah Courtois; Wilfried Souleyreau; Andreas Bikfalvi; Patrick Auguste
Journal:  Front Oncol       Date:  2020-04-28       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.